BioSpace News Archive

Policy

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Cigna Corporation - CI

Juan Monteverde, founder and managing partner at Monteverde & Associates PC is investigating Cigna Corporation

July 26, 2018
·
2 min read
Business

Omnicell Announces Second Quarter 2018 Results

GAAP revenues of $189 million, up 4.2% year-over-year

July 26, 2018
·
69 min read
Business

Amgen Announces Succession Plans For Two Executive Officers

As part of Amgen’s planned executive succession to address upcoming retirements, the Company announced transition plans for two of its executive vice presidents today.

July 26, 2018
·
9 min read
Business

Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018

Expects Revenue Growth of at Least 20% for Fiscal Year 2019

July 26, 2018
·
18 min read
Business

Planet Fitness, Inc. to Report Second Quarter 2018 Results on August 9, 2018

Planet Fitness, Inc. announced that the Company will report results for its second quarter ended June 30, 2018 after the market closes on Thursday, August 9, 2018.

July 26, 2018
·
1 min read
Business

Five Prime Therapeutics to Announce Second Quarter 2018 Financial Results and Host Conference Call on August 8

Five Prime Therapeutics, Inc. will report its second quarter 2018 financial results on Wednesday, August 8, 2018

July 26, 2018
·
1 min read
BioCapital

Senseonics to Participate in the Canaccord Genuity Growth Conference

Senseonics Holdings, Inc. announced the company plans to participate in the upcoming Canaccord Genuity Growth Conference in Boston, MA.

July 26, 2018
·
1 min read
Policy

Statement - CMA’s call to action opens the door for federal government to support much-needed United Nations Convention on the Rights of Older Persons

The Canadian Medical Association (CMA) has been pursuing improved health care and quality of life for our aging population for the past five years.

July 26, 2018
·
1 min read
Deals

HCP Declares Quarterly Cash Dividend on Common Stock

HCP, Inc. announced that its Board of Directors declared a quarterly common stock cash dividend of $0.37 per share.

July 26, 2018
·
1 min read
Drug Development

Principia Confirms Human CNS Exposure and Good Tolerability of Oral BTK Inhibitor PRN2246

Principia Biopharma Inc. today announced that dosing has been completed for all participants in a Phase 1 clinical trial of PRN2246, a Bruton’s tyrosine kinase (BTK) inhibitor designed to cross the human blood-brain barrier.

July 26, 2018
·
2 min read